Condition: Enterococcus Faecalis Infection · Blood Stream Infection · Gut Microbiomes · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Prospective, multicenter, national, observational pharmacological study on the evaluation of efficacy of appropriate monotherapy vs combination treatment for non-complicated Enterococcus faecalis (EF) bloodstream infection (BSI) and identification of gut microbiota fingerprint of patients with EF-BSI correlated to antimicrobial treatment and clinical outcome
This description comes directly from the study's public registry record.
Maddalena Giannella, MD PhD · +39 0512143199 · maddalena.giannella@unibo.it
Always discuss trial participation with your own doctor first.
| Ospedale Maggiore "Carlo Alberto Pizzardi" di Bologna | Bologna, Bologna, Italy | Recruiting |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Bologna, Italy | Recruiting |
| Azienda Ospedaliero Universitaria di Catanzaro "Mater Domini" | Catanzaro, Catanzaro, Italy | Recruiting |
| Humanitas Research Hospital | Milan, Milano, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06833593